Insufficient dose of dietary methyl groups are associated with a host of conditions ranging from neural tube defects to cancer. On the other hand, it is not certain what effect excess dietary methyl groups could have on cancer. This is especially true for prostate cancer (PCa), a disease that is characterized by increasing DNA methylation changes with increasing grade of the cancer. In this three-part study in animals, we look at (i) the effect of excess methyl donors on the growth rate of PCa in vivo, (ii) the ability of 5-aza-2'-deoxycytidine, a demethylating agent, to demethylate in the presence of excess dietary methyl donors and (iii) the effect of in utero feeding of excess methyl donors to the later onset of PCa. The results show that when mice are fed a dietary excess of methyl donors, we do not see (i) an increase in the growth rate of DU-145 and PC-3 xenografts in vivo, or (ii) interference in the ability of 5-aza-2'-deoxycytidine to demethylate the promoters of Androgen Receptor or Reprimo of PCa xenografts but (iii) a protective effect on the development of higher grades of PCa in the "Hi-myc" mouse model of PCa which were fed the increased methyl donors in utero. We conclude that the impact of dietary methyl donors on PCa progression depends upon the timing of exposure to the dietary agents. When fed before the onset of cancer, i.e. in utero, excess methyl donors can have a protective effect on the progression of cancer.
INTRODUCTION
In the absence of knowledge of the kinetics of DNMT-1 from existing studies examining DNMT-1 and SAM, it is difficult to infer what the influence of methyl donors on the activity of DNMT-1 might be. However, a few studies have provided some insight into the relationship.
Psychotic patients exhibit elevated levels of SAM, and in their telencephalic GABAergic neurons, DNMT-1 mRNA expression is increased along with the methylation of promoters like reelin, in conjunction with psychosis (9) . Thus, an association between levels of SAM, from diet or otherwise, and DNMT-1, and methylation of genes is apparent. Consequently, for oncology such an association has been most convincingly demonstrated in experimental studies of colorectal cancer where Young-In Kim has brought to light the importance of optimal timing and dose of folate in determining predisposition and development of tumors (10) .
While observational studies of human populations suggest that lower folate status is associated with an increased risk of colorectal neoplasia, a combined analysis of three large randomized trials of folic acid supplementation for the prevention of advancing to higher grades of adenomas in patients with an adenoma history, revealed no association (11) . On the other hand Mason et al. show that folic acid fortification may have reversed the downward trend in colorectal cancer in the US and Canada resulting in increased incidence of colorectal cancer by as much as 10% (12) populations is the effect of dietary methyl donors on DNA methylation levels and how these changes may be implicated in the carcinogenesis process.
Epigenetic dysregulation is well characterized in prostate cancer (PCa). Worse prognosis of PCa is characterized by increased DNMT-1 expression (14) . In PCa, at least 30 genes including the Androgen Receptor (AR) are hypermethylated (15) . The publication of a study showing increased prostate cancer in patients with higher levels of plasma folate (16) only adds to the enigma of an association between increased methyl donors and PCa. We hypothesized that not only would the growth of PCa be affected by the presence of methyl donors present in a fortified diet or as supplements, but efficacy of pharmacologically useful demethylating agents be influenced by such fortification or supplementation. The PCa cells DU-145 and PC-3 are well studied PCa cell lines which have served as models for methylation studies. While promoters of many genes are methylated in these two cell lines, the DU-145 cell line is exceptionally suitable as the AR promoter is methylated in it. The AR is crucial for the growth and treatment of PCa.
Therefore in this study, first the effect of a methyl proficient diet on the growth of established DU-145 and PC-3 PCa xenografts was evaluated. In the second part of the study, the ability of the drug 5-aza-2'-deoxycytidine (AdC) to demethylate in the presence of excess methyl donors in the diet was examined. Lastly, in the third part of the study, in order to examine the significance of timing of exposure to excess dietary methyl donors, the effects of a methylproficient diet on the initiation and progression of prostate tumors in a developmental mouse model of PCa fed increased methyl donors in utero was examined. By these studies, we 6 demonstrate that in animals prostate carcinogenesis or demethylation by AdC is not adversely affected by excess dietary methyl donors but, depending upon timing of exposure the latter may be protective towards the progression of PCa. The finding is significant in view of the ambiguity in epidemiological studies linking dietary methyl donors to cancer occurrence/progression.
MATERIALS AND METHODS

Cell Culture and Reagents
The DU-145 and PC-3 PCa cell lines, were obtained from American Type Culture Collection (Manassas, Virginia) and low passage numbers aliquoted and frozen at -80°C until use. They were cultured and maintained in 5% CO 2 at 37°C in RPMI 1640 (Invitrogen, Grand Island, NY), supplemented with 10% fetal bovine serum (Invitrogen, Grand Island, NY). The DU-145 and PC-3 PCa cell lines were tested before animal experimentation and found to be mycoplasma free by a PCR based MycoDtect kit from Greiner Bio-One performed at the Johns Hopkins Core facility. The Myc-PCa cell line was a generous gift from Dr. Charles Sawyers and was cultured in DMEM medium (Gibco) supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin at 37°C, 5% CO 2 . The Myc-PCa cell line was not tested after arrival in our laboratory. The AdC was obtained from Sigma-Aldrich (St.Louis, MO). A stock solution of 7 was obtained prediluted from Ventana Medical Systems (Tucson, AZ) and secondary rabbit antibody was from DAKO Cytomaton (Denmark).
Animals
Athymic nu/nu male mice were purchased from Cancer Research Facility, Frederick, MD. 
Diets
Two groups of mice were fed either regular rodent diet (Teklad Global 18% Protein Rodent Diet) called Reg diet or the same regular diet supplemented with the methyl donors: Lmethionine, choline chloride, betaine, folic acid, vitamin B12 and zinc sulphate, called Me diet (Table 1) .
Tumor Growth in vivo
Evaluation of effect of Me diet on growth of PCa and interference of AdC effects in vivo was done by growing xenografts of DU-145 and PC-3 cells in athymic nu/nu male mice with a median weight of 30g. All animal experiments were carried out with the approval of the ethical committee (University Animal Care and Use Committee, Johns Hopkins University). DU-145 and PC-3 cells were cultured as described. One million DU-145 cells and 50,000 PC-3 cells suspended in 50% matrigel were transplanted subcutaneously into the hind flank of each animal through 25G 5/8 needles. Mice were randomized into 4 groups with 8-10 mice per group.
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Two groups were fed Reg diet and the other two Me diet. One group from each dietary group was treated 5 times a week with 0.25mg/kg body weight AdC for 4 weeks -a schedule determined after previous optimizations involving doses up to 1mg/kg body weight (17). The two remaining groups were injected equivalent amounts of saline. Drug / saline treatment was started 2 weeks after implantation, at which point the tumors were palpable. Tumor size was measured once in 4-5 days and tumor volume was calculated according to the formula 0.5326*L*W*H (18) . The weights of all mice were measured weekly. Mice were sacrificed after 4 weeks of treatment with AdC or saline by CO 2 overdose followed by cervical dislocation.
Tumors were excised and portioned. Portions were either immediately frozen in liquid nitrogen, or fixed in 10% neutral buffered formalin for 24hrs, washed and subsequently embedded in paraffin.
Immunohistochemistry
Paraffin embedded tissues were sectioned to 4μm thickness and fixed on poly-L-lysinecoated slides. Slides were deparaffinised, rehydrated, and washed twice in PBS just prior to staining. Ki-67 staining was performed as described earlier (19) . Stained slides were scanned using the Bacus Laboratories Image Scanning System (BLISS). The images were uploaded onto a computer and quantitated using Frida, software for quantitation developed by the Johns Hopkins Medical Institutions' Pathology Division.
Bisulphite Sequencing of AR and Reprimo
Cancer Research. Genomic DNA was isolated from frozen portions of DU-145 xenografts using a SDS based lysis buffer followed by phenol-chloroform isolation. Presence of methylation in promoter region of AR and Reprimo was determined by the methods of Frommer and Clark (20) . In brief:
DNA (1μg) was converted with sodium bisulfite using the EZ DNA methylation kit (Zymo Research, Orange, CA) according to the manufacturer's instructions. A 377 bp AR and a 305 bp Reprimo promoter region was amplified from the bisulfite treated DNA by a PCR reaction using AR and Reprimo-promoter specific primers designed using mspprimer.org, set at the default parameters. The primer sequences are AR forward: AAAAGGAGGTGGGAAGGTAA and AR reverse:
AATCCTACCAAACACTTTCCTTACTTC, and Reprimo forward:
AGAAGAGTATAGTGATTTTTGTTTG and Reprimo reverse: ACAACTAAACTCTTCTAAAACC. PCR was performed with High-fidelity Taq polymerase (Invitrogen) following the protocol: an initial incubation at 95°C for 2mins, followed by 35 cycles of 95°C for 30s, 55°C for AR and 60°C for Reprimo for 30s and 72°C for 40s, followed by one cycle of 72°C for 10mins. PCR products were separated on 2% agarose gels and visualized by SYBR Gold staining. The correct band size was the only product on the gel and was excised and the DNA extracted using a DNA-gel extraction kit (Qiagen). The purified DNA was cloned into TOPO vector using the TOPO TA cloning kit 
Development of Prostate Tumors in "Hi-myc" Mice on Me Diet
The "Hi-myc" mouse was used to study the effect of timing of exposure to methyl donors.
This model has an advantage over existing mouse models to study PCa because the development of adenocarcinoma type of PCa in this model closely recapitulates the same pathological occurrence in human PCa patients (21) . "Hi-myc" mice were fed either Reg or Me diet during gestation, birth of pups and until pups were one month of age. At this time, pups were weaned off the diet and maintained on Reg diet until sacrificed. To see the effects the diets had on the pathology of prostate tumors, the mice were sacrificed at different time points of H&E stained prostate tissues were scored into four grades from 1-4, where 1=Benign, 2=mPIN, 3=Microinvasive, and 4=Invasive adenocarcinoma as defined by the Mouse Models of Human Cancer Consortium prostate pathology committee (22) . Measurements of significant differences between groups were carried out by One-way ANOVA followed by Bonferroni's multiple comparison test. There were 7-14 mice in each group used for the comparison.
Global DNA Methylation
Global methylation levels were determined in 5 months old "Hi-myc" mouse fed either Reg or Me diet. DNA was isolated from frozen portions of the prostatic tissue. The ratio of methylated Cytosine to Cytosine was measured by mass spectrometry following previously published protocols by the Analytical Pharmacology Core at Johns Hopkins Kimmel Cancer Center (M. Rudek-Renaut, Director).
Quantitating Methyl Donors: Folate, Methionine and Homocysteine
To quantitate the levels of circulating and tissue methyl donors during the exposure to Me diet, five month old "Hi-myc" mice were fed either Reg or Me diet for 1 week. On the last day of feeding, blood was collected by cardiac puncture. Mice were sacrificed after blood was collected and prostates isolated. 
Statistical Analysis
All figures and statistical analysis were done using GraphPad Prism 5 software.
RESULTS
In vivo Effect of Methyl Proficient Diet on PCa xenografts i. On Growth of Xenografts
Xenografted DU-145 cells and PC-3 cells developed into palpable tumors 2 weeks after inoculation into immunodeficient mice at which point measurements were begun. In 4 weeks, the DU-145 tumor volume increased 18 fold in mice on Reg diet while it increased 19 fold in mice on Me diet. In the case of PC-3 cells, in 4 weeks, the tumor volume increased 22 fold in Reg diet-fed mice and 23 fold in the Me diet-fed mice. Thus, there was no difference in the rate at which these xenografts grew in mice whether fed standard Reg diet or one fortified with methyl donors -i.e. Me diet (Figure 1a) .
ii. On Effect of AdC
At the end of the 4 week AdC /saline treatment, the relative volume of DU-145 xenografts had 
Effect of Methyl Proficient Diet on Demethylation of AR and Reprimo by 5-aza-2'-deoxycytidine in vivo
Since demethylation of hypermethylated genes in tumor clones is a target effect of AdC 
16 decrease in methylation density of Me diet-fed mice that were treated with AdC for 4 weeks of 47% for AR and 87% for Reprimo. To summarize, with AdC treatment, there is a 32% and 47% decrease in methylation of AR promoter in Reg and Me diet-fed mice, respectively, while there is a greater decrease in the methylation of the Reprimo promoter of 92% and 87% in Reg and Me diet-fed mice, respectively. In saline treated mice, while there is a trend towards a decrease in methylation of promoters in Me diet-fed mice compared to the promoters of the same genes in mice fed Reg diet, this decrease was not significant.
Effect of Methyl Proficient Diet on Development of Prostate Tumors in "Hi-myc" Mice
No difference was noted between the total body weights or the weights of prostates between age matched Me diet-fed and Reg diet-fed "Hi-myc" mice. -7 month old age group was seen. However, as the Me diet-fed mice grew older than 6 months, an age dependent increase in grades now began to appear. Me diet-fed 6 -7 month old mice had higher grades than Me diet-fed 5 -6 month old mice. There was a noticeable absence of a higher grade (grade 4) tumor in Me diet-fed mice vs. Reg diet-fed mice.
Effect of Methyl Proficient Diet on Levels of Circulating and Tissue Me donors -Folate,
Methionine and Homocysteine
Folate levels were 84.59 ± 5.127ng/mL, n=18 and 150.2 ± 25.19ng/mL, n=8 in Reg diet and Me diet-fed mice, respectively (Figure 4a ). Thus, mice on the Me diet have ~2 fold higher mean levels of circulating folate in their plasma than mice on Reg diet (P=0.0014). Differences in sample numbers analysed are due to the fact that blood samples that showed traces of hemolysis were excluded from the analysis to avoid confounding of results by folate from RBCs.
Methionine levels in mice were 7.24 ± 0.9872 µg/mL in Reg diet-fed group and 19.32 ± 2.328 µg/mL in Me diet-fed group; n=4 for each group (Figure 4b) . Thus, mice fed the Me diet had ~3 fold higher mean levels of circulating methionine in their plasma than mice fed Reg diet (P=0.031). The prostate methionine levels were in the range of 20 -40µg/gm of prostate organ wet weight in the case of Reg diet-fed mice and 30-40µg/gm of prostate organ wet weight in the case of Me diet-fed mice (Figure 4c ). The mean levels of methionine in the prostate of Me diet-fed mice (32.88 ± 2.024ug/gm) though not significant, tended to be higher than the corresponding mean levels in the prostates of Reg diet-fed mice (28.44 ± 3.930 µg/gm); n=4 for each group. Homocysteine levels in plasma in both dietary groups were below levels of 
Effect of Methyl Proficient Diet on Global Methylation Levels
5 "Hi-myc" mice fed Reg diet and 10 "Hi-myc" mice fed Me diet following the same regimen as described in the histopathological section, were sacrificed at 5 months of age. The mean ratio of methyl-Cytosine to Cytosine in DNA was determined by mass spectrometry to be 4.3% and 4.5% in the Reg diet and Me diet-fed groups, respectively ( Figure 5 ). Thus, no significant difference in global methylation levels in DNA from prostates between the two dietary groups was observed. Similarly, no significant difference in methylation of promoter of AR in the two groups was seen (results not shown).
Effect of Methyl Donors on Expression of the c-Myc Oncogene
In order to rule out the possibility that dietary methyl donors were affecting c-Myc transgene expression even before the surge in androgen levels in the Hi-myc mice, we examined c-Myc protein levels in Myc PCa cells by Western blots (Figure 6 ) and found similar amounts of c-Myc protein for regular media, one fortified with folate, and one in cells that were first grown in fortified media for 7 days followed by regular media for another 7 days. In chemoprevention studies, agents are administered at a high dose that approximates the maximum tolerated dose for that agent. Because the excess methyl donors did not influence growth of preformed tumors or the ability of AdC to demethylate, it does not mean that the diet was insufficiently loaded with methyl donors or a lack of oral bioavailability.
DISCUSSION
Measurements of circulating methyl donors -folate and methonine, showed that these donors were present in at least 2-fold and 3-fold greater amounts, respectively, than the levels circulating in mice on Reg diet. Thus, the levels of methyl donors were actually much higher than the recommended daily requirement of rodents. A similar methyl-proficient diet was shown to have epigenetic effects in the agouti mouse model (26) . The agouti locus may be more sensitive to methylation changes than either the AR or Reprimo loci examined here. The time frame of exposure to dietary methyl donors and the time elapsed since the exposure and analysis may be differentiating factors in measuring methyl dependent effects too. The body weights of age matched athymic nude or "Hi-myc" mice on Reg or Me diet were not different indicating that the total caloric intake of mice from either dietary group was not different. Thus, a lowered caloric intake could not have occurred, eliminating the reasoning that the protective effects of the Me diet on the growth of the cancer is due to the protective effects of caloric restriction on cancer-as has been observed in other experiments (27) . 
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DNMT-1 hypomorphic alleles reduce the frequency of CpG island methylation in the normal mucosa and intestinal polyps (28) . An increased level of DNMT-1 gene expression in some types of cancer (29) No change in methylation of AR or Reprimo promoters was noted in DU-145 tumors from mice fed the methyl proficient-diet compared to the same regions from mice fed their regular diet, may imply that a threshold of circulating methyl donors is already present in Reg diet. An increase in methyl donors beyond the levels already present does not have a noticeable effect on the promoters assayed here. The lack of noticeable differences may be a result of the fact that some of the methyl donors -L-methionine, betaine, zinc sulphate, Vitamin B12, and folic acid are water soluble. When tissue storage capacity of water soluble vitamins is saturated, the rate of excretion of these increases sharply.
The markers of methylation change used in this study (AR and Reprimo) are significant because they are known to be methylated in PCa. Since the results also show that the extent of 
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DNA demethylation by demethylating agents is gene-specific -AR undergoes less demethylation by AdC compared to Reprimo, it lends credence to the fact that different regions of the genome are differently susceptible to (de)methylation. While it has not been explored here, it may be that the structure of the chromatin around the gene may influence the methylation state of that gene / promoter. Other X-chromosome genes have also been shown to be differentially demethylated when exposed to AdC when compared to genes on other chromosomes (34) . Therefore, overall changes in methylation state, global methylation, may not provide a comprehensive picture of the dynamics involved in achieving the final methylation state. Indeed, global methylation differences were not apparent in the third part of this study where the ratio of Methyl-Cytosine to Cytosine was measured for DNA from 5 month old "Hi-myc" mice fed Me diet when in utero and weaned off the diet when they were 1 month old compared to DNA from Reg diet-fed "Hi-myc" mice of the same age. Further, it may be that a threshold of methylation density exists in promoters and once this threshold methylation density is reached, no further increase in methyl donors changes the methylation on these sites.
As reported in the original paper of the "Hi-myc" mice (21) , in this study too, there was an age-dependent increase in the grade of tumors in myc positive genotypes on Reg diet. In the present paper, "Hi-myc" mice were fed either Reg or Me diet while in utero, at birth and until one month of age. At this time, Me diet-fed mice were weaned off the diet and fed Reg diet until they were sacrificed at different time points between 3 months and 7 months of age to This result was contrary to our hypothesis as well as the observation in xenografts where the phenotype / proliferation / methylation of promoters of xenografts from Reg diet-fed mice was not different from xenografts from Me diet-fed mice. In the case of the "Hi-myc" mice that were fed Me diet in utero and after birth only for an additional month, the significant differences in grades between groups of mice on different dietary regimens were only seen in the 5-7 month age group. If the different diets contributed to these differences in grade then it must be a residual effect of the exposure that is retained in some form of a "memory molecule" that manifests itself at the conducive time. In the present study, the conducive time was when the mice were of the ages of 5 months or higher. This is the period when the transition from mPIN to cancer takes place. According to the original paper describing the development of tumors in "Hi-myc" mice, at 6 months or higher, all "Hi-myc" mice developed invasive cancer. A previous exposure to Me diet may be influencing the mechanisms at play during the transitionary period from mPIN to invasive cancer. Our in vitro studies show that exposure to methyl donors does not affect the expression of the c-myc-transgene. Further studies are warranted, including maintaining Hi-myc mice on Reg and Me diet since weaning and not in utero and observing cancerous changes that may be occurring.
Such a delayed effect of maternal Me donor supplementation was also described by Cropley et al., (25) . Cropley et al., Significant difference between the grades due to age (#) or dietary exposure (*) at P ≤ 0.05 by ANOVA followed by Bonferroni's multiple comparison test, are marked; ns= not significant. Myc-PCa cells grown in regular media (lane1), one fortified with folate (lane2), and one in cells that were first grown in fortified media for 7 days followed by regular media for another 7 days 
